Bi-allelic BRCA1 mutations are likely to be lethal at the embryonic stage, while such mutations in BRCA2 lead to Fanconi anemia type D1, with increased risk of childhood cancer (FitzGerald et al., 1998; Moatter et al., 2011). This evidence concerns the gene BRCA2 and childhood malignant neoplasm.